-
Brean Murray Carret & Co. Report On Share Repurchase For ANR
Tuesday, August 23, 2011 - 7:46am | 168Brean Murray Carret & Co. is maintaining its Buy rating and its $63 price target on Alpha Natural Resources (NYSE: ANR) in light of a large repurchase authorization granted to the company. According to Brean Murray Carret & Co., “Yesterday after close, Alpha Natural Resources announced a...
-
Brean Murray Carret Assumes Coverage On Chesapeake With Hold Rating
Wednesday, July 6, 2011 - 7:13am | 65According to Brean Murray Carret, Chesapeake Utilities (NYSE: CPK) coverage is assumed with a Hold rating. Brean Murray Carret said that it is assuming coverage with a Hold rating due to valuation. “We recommend investors wait to find a more attractive entrance point before adding to / taking new...
-
Brean Murray Carret & Co. Raises PT On CWCO To $13
Thursday, May 12, 2011 - 8:00am | 170Brean Murray Carret & Co. has raised its price target from $12 to $13 on Consolidated Water Co. (NASDAQ: CWCO) following the release of 1Q11 results. According to Brean Murray Carret & Co., “1Q11 results cam in just short of expectations, primarily due to higher costs related to the...
-
Brean Murray Has Buy On EMC (EMC)
Thursday, April 21, 2011 - 7:44am | 42Brean Murray Carret & Co. has a Buy rating and a $33 price target on shares of EMC Corporation (NYSE: EMC) after it reported earnings. Shares of EMC gained $1.24 yesterday to close at $27.96, a gain of 4.6%.
-
UPDATE: Brean Murray Upgrading Idex To Buy (IDEX)
Thursday, April 21, 2011 - 7:42am | 37Brean Murray Carret & Co. is upgrading shares of IDEX Corporation (NYSE: IDEX) to Buy from Hold, and it has a $53 price target on shares. Shares of IDEX gained 89 cents yesterday to close at $44.54, a gain of over 2%.
-
Brean Murray, Carret & Co. Preview 1Q In Retail And Consumer Products
Tuesday, April 19, 2011 - 7:46am | 184Brean Murray, Carret & Co., in a report previewing 1Q numbers in the retail industry is reiterating its Buy rating on the apparel industry. Says Brean Murray, Carret & Co., in the report, “We believe there are a number of specific and general factors which should allow for the apparel...
-
Brean Murray, Carret & Co. Lowers Estimates On Coach, Inc.
Tuesday, April 5, 2011 - 7:56am | 46Brean Murray, Carret & Co. has lowered its estimates on Coach, Inc. (NYSE: COH) in light of the tragedy in Japan. The company maintains its Buy rating, however, as well as its price target of $65. COH closed yesterday at $52.93.
-
Brean Murray, Carret & Co. Maintain Rating on CHC
Monday, April 4, 2011 - 8:34am | 45Brean Murray, Carret & Co. is maintaining a Buy rating on China Hydroelectric Corp.(NYSE: CHC) based on reports from 4Q10 and a successful year in general. The price target on CHC remains at $10. CHC closed at $7.25 Friday.
-
Brean Murray Carret & Co Raises PVH PT To $80
Tuesday, March 29, 2011 - 8:27am | 76Brean Murray Carret & Co has reported a raised price target on Phillips-Van Heusen Corporation (NYSE: PVH) from $70.00 to $80.00. According to the report, "We are reiterating our Buy Rating, raising our price target to $80 (from $70), increasing our FY12 EPS to $4.92 (from $4.67) and rolling...
-
Brean Murray Has Buy On Xerox (XRX)
Friday, February 11, 2011 - 1:38pm | 161Brean Murray Carret & Co. has a Buy rating and a $14 price target on shares of Xerox Corporation (NYSE: XRX). In a note to clients, Brean Murray writes, "We hosted meetings with Xerox and want to remind investors of key points commensurate with our “Buy Reiteration” call coming off of Dec Q...
-
Brean Murray, Carret & Co. Raises IM Target To $23 From $22
Friday, February 11, 2011 - 8:41am | 26Brean Murray, Carret & Co. is raising its PT on shares of Ingram Micro Inc. (NYSE: IM) to $23 from $22.
-
Brean Murray Carret & Co. Reiterates Onyx Pharmaceuticals Buy Rating, $38 PT (ONXX)
Tuesday, February 1, 2011 - 10:42am | 116Brean Murray Carret & Co. reiterated its Onyx Pharmaceuticals (NASDAQ: ONXX) Buy rating and price target of $38 in a research report published today. In the report, Brean Murray Carret & Co. states, "Last night, Onyx announced that the FDA has granted fast track designation for carfilzomib...
-
Brean Murray, Carret & Co. Initiates CHC At Buy, $10 PT
Thursday, January 27, 2011 - 9:53am | 26Brean Murray, Carret & Co. is initiating coverage of China Hydroelectric Corporation (NYSE: CHC) at Buy with a $10 PT.
-
EMC Top Pick At Brean Murray (EMC)
Monday, January 24, 2011 - 9:48am | 116Brean Murray, Carret & Co. has a Buy rating and a $30 price target on shares of EMC Corporation (NYSE: EMC). In a note to clients, Brean Murray writes, "While we remain net-long our universe heading into the year, in this piece we delineate between our Buy rated names; specifically, Xerox,...
-
Brean Murray Anticipates Street-Beating Results For WDC And STX
Friday, January 14, 2011 - 9:45am | 163In a report released this morning, Brean Murray, Carret & Co. said that it believes that both Western Digital Corporation (NYSE: WDC) and Seagate Technology (NASDAQ: STX) can report Dec. Q results a bit better than the Street and guide to solid March Q results when they report next week. “For...